Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lechleider Robert Insider Profile
4 Followers
Lechleider Robert, CMO at Immunome, holds 15.80K shares in Immunome (Ticker: IMNM). Most recently, Lechleider Robert Bought $15,805 shares of Immunome on Nov 25, 2024 for an estimated value of 149.67K.
Lechleider Robert has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Lechleider Robert's holdings
Insider Roles
CMO
Roles that Lechleider Robert holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Lechleider Robert
Lechleider Robert's Trading History
List of latest transactions for each holding click on a transaction to see Lechleider Robert's performance on stock
You May Also Like
Lechleider Robert insider profile FAQ
What is the percentage of profitable transactions made by Lechleider Robert?
The percentage of profitable transactions made by Lechleider Robert is ―.
What is the average return per transaction made by Lechleider Robert?
The average return per transaction made by Lechleider Robert is ―.
What stocks does Lechleider Robert hold?
Lechleider Robert holds: IMNM stocks.
What was Lechleider Robert’s latest transaction?
Lechleider Robert latest transaction was an Informative Buy of $149.67K.
What was Lechleider Robert's most profitable transaction?
Lechleider Robert’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Lechleider Robert's role in Immunome?
Lechleider Robert's role in Immunome is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.